Datum Källa Rubrik Typ Alternativ
2022-11-22 Coala Life Coala Life confirms the financial targets Analyser Ladda ner | Visa Stäng
2022-11-22 Coala Life Coala Life bekräftar de finansiella målen Analyser Ladda ner | Visa Stäng
2022-11-16 Coala Life Coala-Life Group AB Kvartalsrapport tre 2022 Analyser Ladda ner | Visa Stäng
2022-11-16 Coala Life Coala Life nyckeltal oktober, USA Analyser Ladda ner | Visa Stäng
2022-11-16 Coala Life Coala-Life Group AB quarter three 2022 Analyser Ladda ner | Visa Stäng
2022-11-16 Coala Life Coala Life October monthly KPI’s USA Analyser Ladda ner | Visa Stäng
2022-11-15 Coala Life Coala Life ingår konvertibel lånefacilitet om 25 MSEK med befintliga aktieägare Analyser Ladda ner | Visa Stäng
2022-11-15 Coala Life Coala Life enters into a convertible loan facility of SEK 25 M with existing shareholders Analyser Ladda ner | Visa Stäng
2022-10-25 Coala Life Coala Life reports monthly key figures for the company’s main market, USA Analyser Ladda ner | Visa Stäng
2022-10-25 Coala Life Coala Life rapporterar månadsvisa nyckeltal för bolagets huvudmarknad USA Analyser Ladda ner | Visa Stäng
2022-08-24 Coala Life VD köper aktier i Coala-Life Group AB (publ) Analyser Ladda ner | Visa Stäng
2022-08-24 Coala Life CEO buys shares in Coala-Life Group AB (publ) Analyser Ladda ner | Visa Stäng
2022-08-22 Coala Life Intervju med Coala Lifes VD, Dan Pitulia om förvärvet av Vitrics Management Group Inc och Q2 rapporten Analyser Ladda ner | Visa Stäng
2022-08-22 Coala Life Interview with Coala Life’s CEO, Dan Pitulia on the acquisition of Vitrics Management Group Inc and the Q2 report Analyser Ladda ner | Visa Stäng
2022-08-17 Coala Life Coala-Life Group AB Kvartalsrapport två 2022 Analyser Ladda ner | Visa Stäng
2022-08-17 Coala Life Coala-Life Group AB quarter two 2022 Analyser Ladda ner | Visa Stäng
Analyser | 17 Aug 2022 | Coala Life

Coala-Life Group AB quarter two 2022

Second quarter 2022

  • Net sales increased to SEK 1.6 M (0.9).
  • EBITDA totaled SEK -40.7 M (-9.0).
  • Operating income totaled SEK -41.4 M (-9.8).
  • Profit after tax was SEK -38.5 M (-9.8).
  • Earnings per share was SEK -0.6 (-4.8).
  • Cash flow from operating activities was SEK -50.9 M (-10.2).

The period, January 1, 2022 – June 30, 2022

  • Net sales increased to SEK 2.4 M (2.2).
  • EBITDA totaled SEK -71.6 M (-22.0).
  • Operating income totaled SEK -73.4 M (-23.6).
  • Profit after tax was SEK -70.1 M (-23.7).
  • Earnings per share was SEK -1.3 (-11.8).
  • Cash flow from operating activities was SEK -86.4 M (-24.5).

Events in the quarter

  • On April 13, the company announced a resolution of a fully guaranteed rights issue of approximately SEK 150 M before transaction costs.
  • On April 15, the company announced that it received FDA 510k clearance for remote lung auscultation and enhanced ECG algorithm.
  • In April, the company reported that the Coala Heart Monitor had been recommended by the Medical Technology Product Council for introduction into clinical use in Sweden.
  • On May 30, the Annual General Meeting of Coala-Life Group AB was held, and Christian Jørgensen was elected as a board member.
  • On June 9, the company announced its intention to acquire Vitrics Management, a USA company engaged in patient monitoring.

Events after the end of the quarter

  • On July 4, the company launched a new website.
  • On July 29, the company announced that the estimated completion date of the acquisition of Vitrics Management was moved back to August 14.
  • On August 15, the company announced that the acquisition of Vitrics Management was completed for a purchase price of USD 3.5 M.

Extract from comments from the CEO, Dan Pitulia

During the spring and summer we have continued to work towards a profitable business in the US market. Our venture into Managed RPM, under the name Qorum Partners, has strengthened its position and business is picking up momentum, largely due to an investment in clinical staff. Coala Heart Monitor received an additional FDA 510k clearance in the US, for remote lung auscultation and new ECG analysis algorithm, and, in Sweden, the Medical Technology Product Council (MTP Council) recommended the use of Coala Heart Monitor in Swedish healthcare for patients with symptoms of atrial fibrillation. Shortly before the release of this report, we were also able to complete the acquisition of Vitrics in the US.

2022-08-15 Coala Life Coala Life acquires Vitrics Management for an adjusted purchase price of USD 3.5 million Analyser Ladda ner | Visa Stäng
2022-08-15 Coala Life Coala Life förvärvar Vitrics Management till en justerad köpeskilling om 3,5 miljoner USD Analyser Ladda ner | Visa Stäng
2022-07-29 Coala Life Coala Life ändrar beräknat slutförandedatum av förvärv av Vitrics Management till 14 augusti 2022 Analyser Ladda ner | Visa Stäng
2022-07-29 Coala Life Coala Life changes the estimated completion date of the acquisition of Vitrics Management to August 14, 2022 Analyser Ladda ner | Visa Stäng
2022-07-18 Coala Life Rättelse: VD köper aktier i Coala-Life Group AB (publ) Analyser Ladda ner | Visa Stäng
2022-07-18 Coala Life Correction: CEO buys shares in Coala-Life Group AB (publ) Analyser Ladda ner | Visa Stäng
2022-07-18 Coala Life CEO buys shares in Coala-Life Group AB (publ) Analyser Ladda ner | Visa Stäng
2022-07-18 Coala Life VD köper aktier i Coala-Life Group AB (publ) Analyser Ladda ner | Visa Stäng
2022-07-04 Coala Life Coala Life är glada att kunna meddela lanseringen av vår nya hemsida. Analyser Ladda ner | Visa Stäng
2022-07-04 Coala Life Coala Life is pleased to announce the launch of our new website. Analyser Ladda ner | Visa Stäng
2022-06-10 Coala Life VD köper aktier i Coala-Life Group AB (publ) Analyser Ladda ner | Visa Stäng
2022-06-10 Coala Life CEO buys shares in Coala-Life Group AB (publ) Analyser Ladda ner | Visa Stäng
2022-06-09 Coala Life Coala Life avser förvärva Vitrics Management, ett USA-bolag verksamt inom patientmonitorering Analyser Ladda ner | Visa Stäng
2022-06-09 Coala Life Coala Life intends to acquire Vitrics Management, a US company active in Remote Patient Monitoring Analyser Ladda ner | Visa Stäng
2022-05-30 Coala Life Bulletin from annual general meeting in Coala-Life Group AB (publ) on 30 May 2022 Analyser Ladda ner | Visa Stäng
2022-05-30 Coala Life Stämmokommuniké från årsstämma den 30 maj 2022 i Coala-Life Group AB (publ) Analyser Ladda ner | Visa Stäng
2022-05-24 Coala Life Coala-Life Group AB quarterly report one 2022 Analyser Ladda ner | Visa Stäng
2022-05-24 Coala Life Coala-Life Group AB kvartalsrapport ett 2022 Analyser Ladda ner | Visa Stäng
2022-05-17 Coala Life Coala Life presenterar Q1 rapport via live webcast Analyser Ladda ner | Visa Stäng
2022-05-17 Coala Life Coala Life presents Q1 report via live webcast Analyser Ladda ner | Visa Stäng
2022-04-26 Coala Life NOTICE TO ATTEND THE ANNUAL GENERAL MEETING IN COALA-LIFE GROUP AB (PUBL) Analyser Ladda ner | Visa Stäng
2022-04-26 Coala Life KALLELSE TILL ÅRSSTÄMMA I COALA-LIFE GROUP AB (PUBL) Analyser Ladda ner | Visa Stäng
2022-04-19 Coala Life Coala Heart Monitor is recommended by the Swedish Medical Technology Product Council for clinical use Analyser Ladda ner | Visa Stäng
2022-04-19 Coala Life Coala Heart Monitor rekommenderas av Medicintekniska Produktrådet för införande i klinisk användning i Sverige Analyser Ladda ner | Visa Stäng
2022-04-15 Coala Life Coala Life receives FDA 510k clearance for remote lung auscultation and enhanced ECG algorithm Analyser Ladda ner | Visa Stäng
2022-04-15 Coala Life Coala Life erhåller FDA 510k godkännande för lungauskultation och ny EKG-analysalgoritm Analyser Ladda ner | Visa Stäng
2022-04-13 Coala Life Coala-Life Group tillförs cirka 150 miljoner kronor genom en företrädesemission Analyser Ladda ner | Visa Stäng
2022-04-13 Coala Life Coala-Life Group raises SEK 150 million in a rights issue Analyser Ladda ner | Visa Stäng

Kommande händelser

23 Feb 2023 | Bokslutskommuniké 2022